Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced that the 2018 annual general meeting of the Company the class meeting of the holders of H shares of the Company and the class meeting of the holders of domestic shares of the Company held on 26 April 2019. After the conclusion of the AGM, Class Meeting of Holders of H Shares and Class Meeting of Holders of Domestic Shares, the Company held the eleventh meeting of the sixth session of the Board, in which the Board resolved to elect Mr. Wang Hai Bo, Mr. Zhao Da Jun and Mr. Yang Chun Bao as the members of the Strategy Committee of the Board and Mr. Wang Hai Bo as the chairman. The appointment of members of the Strategy Committee of the Board shall take effect upon the completion of the Proposed Issue of A Shares, and the term of office shall commence from the date of initial public offering of A Shares and its listing on the Sci-Tech Innovation Board of the Shanghai Stock Exchange.